KARLSRUHE, Germany and LOS GATOS, California, March 8 /PRNewswire/ -- joimax medical solutions GmbH Karlsruhe, Germany, announces that it has hired a full time CEO to manage its wholly owned US subsidiary, joimax, Inc. joimax received FDA clearances for all of its products, and specifically for the THESSYS(TM) Transforaminal Endoscopic Spine System, in Q3 of 2005. Since the spring of 2005, initially as a consultant Michael Stek has managed joimax’s activities in the US out of Los Gatos, CA. “With Michael we hired a very experienced and competent Manager from the industry, who will continue to be instrumental in building our business base and activities in the US”, said Wolfgang Ries, Managing Director and Founder of the joimax GmbH. Michael Stek, BSc., brings over 20 years of medical device industry experience to the company. Before joining joimax, Inc., Michael Stek was “Vice-President Sales and Marketing” for NeuColl, Inc., and prior to that he held various positions of growing responsibility, including “Managing Director/Director of Sales”, at Acromed UK and in the US (later DePuy Spine, a Johnson & Johnson Company). Michael Stek and Wolfgang Ries now form the core team of Senior-Management at joimax, to which others will be added as the company expands in the near term. The company is engaged in the development, manufacturing and distribution of technologies for minimally access (invasive) surgical procedures, specifically in spine.
Advisory competence added with new Advisory Board Members In the beginning of 2006 joimax GmbH finalized its Board of Directors. All 5 members bring a wealth of knowledge based on their different business experiences. Verena Eisenlohr (Chairman of the Board), Michael Kranich, Dr.-Ing. Peter Grassmann, Dr. Chris Tanner and Thomas Remmele. The key goal for this Board is to advise the Management Team on strategic and long term decision making processes. “An important step towards strategic orientation and business development has now been initiated”, said Wolfgang Ries, Managing Director, “we feel very positive about this gain in human resources and experience for joimax’s long term success.”
Verena Eisenlohr, LL.M.,
Chairman of the Board, representing the lead investor of the company. As an attorney and partner of the Rittershaus Association, Mannheim, she specializes in company law and acts as adviser for several enterprises within the medtech and biotech environment.
Michael Kranich, Dipl.-Kaufm.,
Representative of the DH-Capital and the OH-Beteiligungen investors companies. An Economist, he is also the Managing Director of the BW Verwaltungs GmbH of Heidelberg.
Dr.-Ing. Peter H. Grassmann,
An acknowledged expert within the industry he was unanimously elected to the Board by the shareholders. The experienced physicist was the CEO at Carl Zeiss, Oberkochen and Jena in Germany, and also Group President and Member of the Board at Siemens Medical AG. He holds several other positions as Director of the Board at companies within the medical industry.
Dr. Chris Tanner,
Named as Member of the Board by the investor, acting as independent consultant of the Dievini GmbH, Heidelberg, a partner of joimax. In leading roles the bank economist was more than 20 years active for the UBS Bank Swiss and holds several Board Member positions in companies of the medical industry.
Thomas Remmele, Dipl.-Ing.,
Elected Member of the Board representing the founding shareholders of joimax GmbH. The informatics and computer science engineer holds the position of Managing Director at the Innomedic GmbH, a partner company of joimax.
Contact: joimax GmbH Tanja Henn Telefon: +49(0)721-255-14-0 Telefax: +49(0)721-255-14-920 tanja.henn@joimax.comwww.joimax.com
joimax GmbH
CONTACT: joimax GmbH, Tanja Henn, Telefon: +49(0)721-255-14-0, Telefax:+49(0)721-255-14-920, tanja.henn@joimax.com, www.joimax.com
